Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

POLYMORPHIC EXPRESSION OF CYP1A2 LEADING TO INTERINDIVIDUAL VARIABILITY IN METABOLISM OF A NOVEL BENZODIAZEPINE RECEPTOR PARTIAL INVERSE AGONIST IN DOGS

Masashi Mise, Seiji Yadera, Michiaki Matsuda, Takanori Hashizume, Satoshi Matsumoto, Yoshiaki Terauchi and Toshihiko Fujii
Drug Metabolism and Disposition February 2004, 32 (2) 240-245; DOI: https://doi.org/10.1124/dmd.32.2.240
Masashi Mise
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seiji Yadera
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michiaki Matsuda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takanori Hashizume
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Satoshi Matsumoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshiaki Terauchi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshihiko Fujii
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 32 no. 2 240-245
DOI 
https://doi.org/10.1124/dmd.32.2.240
PubMed 
14744947

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received August 5, 2003
  • Accepted October 31, 2003
  • Published online January 26, 2004.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Masashi Mise,
  2. Seiji Yadera,
  3. Michiaki Matsuda,
  4. Takanori Hashizume,
  5. Satoshi Matsumoto,
  6. Yoshiaki Terauchi and
  7. Toshihiko Fujii
  1. Pharmacokinetics and Physico-Chemical Property Research Laboratories (M.Mi., M.Ma., T.H., S.M., Y.T., T.F) and Safety Research Laboratories (S.Y.), Dainippon Pharmaceutical Co., Ltd., Osaka, Japan
  1. Address correspondence to:
    Masashi Mise, Pharmacokinetics and Physico-Chemical Property Research Laboratories, Dainippon Pharmaceutical Co., Ltd., 33-94, Enoki, Suita, Osaka 564-0053, Japan. E-mail: masashi-mise{at}dainippon-pharm.co.jp
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 2017063
Sep 20170106
Oct 20171108
Nov 201741913
Dec 20170113
Jan 2018080
Feb 20180141
Mar 2018085
Apr 20180123
May 201801014
Jun 20180146
Jul 201801410
Aug 20181152
Sep 20180124
Oct 20181435
Nov 20180524
Dec 201840166
Jan 20195200
Feb 20193723
Mar 20191831
Apr 20191321
May 20191223
Jun 2019823
Jul 20191021
Aug 20191200
Oct 2019922
Nov 20193012
Dec 20191945
Jan 20201210
Feb 20201200
Mar 2020521
May 20201501
Jun 20201322
Jul 2020800
Aug 2020612
Sep 2020410
Oct 2020920
Nov 2020511
Dec 20201412
Jan 20212262
Feb 2021852
Mar 20211331
Apr 20211533
May 20215540
Jun 20211462
Jul 20211220
Aug 2021551
Sep 20211610
Oct 20214720
Nov 20211912
Dec 20212220
Jan 20221212
Feb 2022932
Mar 20222841
Apr 20223771
May 20221444
Jun 20222027
Jul 20221121
Aug 20221642
Sep 20221835
Oct 20222333
Nov 20222122
Dec 20221631
Jan 20232522
Feb 20232262
Mar 20231132

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 32 (2)
Drug Metabolism and Disposition
Vol. 32, Issue 2
1 Feb 2004
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
POLYMORPHIC EXPRESSION OF CYP1A2 LEADING TO INTERINDIVIDUAL VARIABILITY IN METABOLISM OF A NOVEL BENZODIAZEPINE RECEPTOR PARTIAL INVERSE AGONIST IN DOGS
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

POLYMORPHIC EXPRESSION OF CYP1A2 LEADING TO INTERINDIVIDUAL VARIABILITY IN METABOLISM OF A NOVEL BENZODIAZEPINE RECEPTOR PARTIAL INVERSE AGONIST IN DOGS

Masashi Mise, Seiji Yadera, Michiaki Matsuda, Takanori Hashizume, Satoshi Matsumoto, Yoshiaki Terauchi and Toshihiko Fujii
Drug Metabolism and Disposition February 1, 2004, 32 (2) 240-245; DOI: https://doi.org/10.1124/dmd.32.2.240

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

POLYMORPHIC EXPRESSION OF CYP1A2 LEADING TO INTERINDIVIDUAL VARIABILITY IN METABOLISM OF A NOVEL BENZODIAZEPINE RECEPTOR PARTIAL INVERSE AGONIST IN DOGS

Masashi Mise, Seiji Yadera, Michiaki Matsuda, Takanori Hashizume, Satoshi Matsumoto, Yoshiaki Terauchi and Toshihiko Fujii
Drug Metabolism and Disposition February 1, 2004, 32 (2) 240-245; DOI: https://doi.org/10.1124/dmd.32.2.240
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • AKRs and GUSs in Testosterone Disposition
  • Olanzapine Glucuronidation in Humanized Mice
  • rs2242480 Regulates the Expression of CYP3A4 and CYP3A5
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics